跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
喜达诺 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ustekinumab Injection (Intravenous Infusion)
Approved
生物制品
Ustekinumab Injection (Intravenous Infusion)
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Mar 11, 2020
Approval ID
7w10uDIbzFD
Company
Janssen-Cilag International NV
Type
生物制品
Approval Details
Approval Id
7w10uDIbzFD
Approval Number
S20200005
Generic Name
乌司奴单抗注射液(静脉输注)
Generic Name En
Ustekinumab Injection (Intravenous Infusion)
Trade Name
喜达诺
Brand Name
喜达诺
Drug Type
生物制品
Dosage Form
注射剂
Strength
130mg/26ml/瓶
Reg Date
2020-03-11
Expired Date
2025-03-10
Company Name
Janssen-Cilag International NV
Company Address
Turnhoutseweg 30, B-2340 Beerse, Belgium
Production Company Name
Cilag AG
Production Company Address
Hochstrasse 201, 8200 Schaffhausen, Switzerland
Company Detail Path
/organization/janssen-cilag-international-nv
Production Company Detail Path
/organization/cilag-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 11, 2020
Approval ID
7w10uDIbzFD
Type
生物制品
Back to NMPA Approvals
